Skip to content
DeepLife logo

DeepLife Alternatives & Competitors

12 companies similar to DeepLife — AI for digital twin of cells

Companies similar to DeepLife

Ascent Bio logo — alternative to DeepLife

Ascent Bio

Building the future of molecule intelligence

Terray Therapeutics logo — alternative to DeepLife

Terray Therapeutics

Everything small molecule drug discovery should be.

Scailyte logo — alternative to DeepLife

Scailyte

True precision medicine through single-cell science.

Genesis Molecular AI logo — alternative to DeepLife

Genesis Molecular AI

Unifying AI and Biotech to accelerate the discovery of new medicines

Rival Readout

Competing with DeepLife? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
iktos logo — alternative to DeepLife

iktos

Artificial intelligence for new drug design

Aignostics logo — alternative to DeepLife

Aignostics

AI-powered tissue analysis, validated by pathologists

AMPLY Discovery logo — alternative to DeepLife

AMPLY Discovery

Turning the Dark Genome into Novel Medicines.

Standigm logo — alternative to DeepLife

Standigm

The workflow AI drug discovery company

Insilico Medicine logo — alternative to DeepLife

Insilico Medicine

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...

BEYOND GENOMiX logo — alternative to DeepLife

BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease di...

Recursion logo — alternative to DeepLife

Recursion

Decoding Biology to Radically Improve Lives

Atomwise logo — alternative to DeepLife

Atomwise

Better Medicines Faster

About DeepLife

DeepLife, an innovative startup founded in 2019, is making significant strides in biotechnology by developing the first SaaS platform for creating a Digital Twin of cells. They leverage advanced AI and machine learning to transform cell engineering by simulating cell behavior in silico, aiming to complement traditional...

Services

Development of digital twins for cells, Drug discovery solutions, Multi-omics data analysis, AI and systems engineering for biotech applications

Target Customers

Pharmaceutical companies, Biotech researchers, Health institutions, Investors interested in biotech innovations, Scientific collaborators

Business keywords

Digital Twin, Cell Engineering, SaaS Platform, Multi-omics Sequencing, Deep Learning Algorithms, In Silico Simulations, Pharmaceutical Target Identification, Molecular Triggers, System Biology, Translational Research, Biotech Collaboration, Cell Atlases, Deep Learning-Based Tools, Drug Discovery

Business Model

SaaS, B2B, Platform

Revenue Model

Subscription, Usage Based, Licensing

Frequently Asked Questions

Companies similar to DeepLife include Ascent Bio, Terray Therapeutics, Scailyte, Genesis Molecular AI, iktos. They work in AI and Biotechnology and share DeepLife's focus on drug discovery, biotech collaboration and translational research.
Bounce Watch lists 12 companies that share DeepLife's industries and are closest to it in business tags, services, target customers, business model and size.
DeepLife, an innovative startup founded in 2019, is making significant strides in biotechnology by developing the first SaaS platform for creating a Digital Twin of cells. They leverage advanced AI and machine learning to transform cell engineering by simulating cell behavior in silico, aiming to complement traditional...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around DeepLife: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at DeepLife on 15 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout